display
Britain has secured preferred treatment from vaccine maker AstraZeneca, according to British Health Minister Matt Hancock.
Looking at the dispute between the EU and AstraZeneca over reduced delivery volumes, Hancock told the Financial Times on Thursday: “Our contract trumps them.
This is called contract law and is clear. ”The EU has a contract that only guarantees“ best efforts ”on the part of the vaccine manufacturer, while London has stipulated exclusivity.
Hancock warned Brussels against imposing export restrictions on vaccines.
That would be a serious mistake, said the conservative politician.
“I believe that free trading nations adhere to contract law”.
Life sciences companies would move to the UK, not a protectionist EU.
“From the UK you can export anywhere in the world - we will never put a stop to that”.
The EU complains that while millions of vaccine doses have been delivered from the continent to the UK in recent months, almost nothing has gone in the opposite direction.
Hancock emphasized that discussions with the EU about this were "cooperative, practice-oriented and collaborative".
The heads of state and government of the EU want to discuss the vaccine shortage on Thursday.
AstraZeneca had drastically cut its delivery commitment several times and pointed out difficulties in production.
Great Britain is hardly affected by this.
display
Buy antigen self-tests online now
Take a nasal swab, read the result on the test strip within 15 minutes and find out whether you have Covid-19.
Order 5 pieces from Galeria Kaufhof Order 10 pieces from APONEO Order 25 pieces from APONEO
All developments in the live ticker